• Latest Posts

Forbion raises €1.35B to invest in life science companies

Opinion 28 Feb 2023

Life changing treatments for rare disease – a beacon of hope

Beyond Biotech podcast 1: Forbion, OMass, PharNext

New Forbion life sciences fund hits €470M

Biotech Stocks in “Total Eclipse” as Financial Pressures Mount

European Biotech Investors Cap Off Record Year in Fundraising


Forbion Raises €185M to Fuel Late-Stage European Biotechs

More News! 19 Nov 2018

Anti-Inflammatory Treatments Get €40M Boost in Series B

Update: Forbion’s Life Science Fund Tops Goal by €90M

British Biotech Raises £29M Round to Fight Lung Disease

New Dutch Biotech Sails Straight into Phase II with €25M Series A to Treat NASH

Interview 20 Jun 2017

“We’re at a second revolution in cancer therapy” – Experts discuss the Future of Oncology at Refresh